Stories

Dual use of cigarettes and e-cigarettes has become a central point of contention in the harm reduction debate. Analysis by Arielle Selya suggests that while complete switching is ideal, reducing cigarette consumption through dual use can still lower overall exposure to harmful substances. However, many studies cited against dual use are criticised for methodological flaws, including poor comparisons between different groups of users. These limitations may lead to overstated risks associated with vaping and misunderstandings about real-world behaviour. The discussion ultimately reflects broader tensions over how evidence is interpreted and applied in shaping harm reduction policies.

Visual storytelling is becoming an increasingly important tool in shaping the global conversation on tobacco harm reduction. A new initiative developed by Knowledge Action Change aims to build a comprehensive, freely accessible image library documenting nicotine products and their real-world use. The collection captures a wide range of contexts, from modern vape shops to traditional tobacco practices across different regions. Designed for journalists, researchers and advocates, the resource seeks to improve how harm reduction is represented and understood worldwide. By providing accurate and diverse visual materials, the project addresses gaps in public communication and challenges misleading narratives.

Criticism is mounting over how youth vaping trends are being presented in Canada’s public debate. Recent commentary argues that government-funded advocacy groups are misrepresenting data to justify stricter regulations on vaping products. Official figures from Health Canada indicate that youth vaping rates have actually declined significantly in recent years. At the same time, campaigners continue to push for flavour bans, which critics say could undermine harm reduction efforts for adult smokers. The controversy raises broader concerns about whether public health messaging is being driven by evidence or by institutional and political interests.

The Tobacco Free Generation measure is criticized for solving an already addressed issue and neglecting the population at immediate risk of smoking-related diseases. The legislation unfairly targets vaping, disregarding harm reduction strategies that could benefit adult smokers. Driven by exaggerated fears about youth vaping, it fosters negative perceptions and fails to support public health effectively. The approach also risks fueling illicit markets and lacks justification while overreaching beyond smoking products. The measure's infringement on adult autonomy sets a concerning precedent. A focus on pragmatic, evidence-based public health policies is needed to address smoking effectively and protect adult autonomy.

Tensions are rising within the US administration over the future of flavoured nicotine products. Reports suggest that the head of the U.S. Food and Drug Administration is resisting pressure from the White House to relax restrictions on flavours. The dispute highlights internal divisions over how to balance youth protection with harm reduction strategies. Critics argue that limiting flavoured alternatives could reduce options for adult smokers trying to switch. The situation reflects a broader struggle over how nicotine policy should be shaped and on what evidence.

Concerns over public health policies are intensifying as critics question the direction of nicotine regulation. A controversial report has been accused of misrepresenting scientific evidence on nicotine and its effects. Experts argue that key claims—such as equating vaping with smoking risks—are unsupported or misleading. The debate highlights tensions between regulatory approaches and harm reduction strategies, particularly in Europe. At its core lies a broader question of whether current policies are driven by evidence or ideology.

Lawmakers in Iowa are moving to introduce a new tax on alternative nicotine products, signaling a shift in how these categories are regulated. The proposal sets a 5-cent levy on nicotine pouches and a per-milliliter tax on e-liquids used in vaping products. The measure would apply broadly across both disposable devices and refill systems, creating a more uniform approach to taxation. Supporters argue the policy is aimed at generating funding for pediatric cancer research rather than significantly reducing usage. Critics, however, question whether such a modest tax can meaningfully influence consumer behaviour or public health outcomes.

A newly proposed EU Tobacco Excise Directive revision suggests a 400% tax increase on Swedish nicotine pouches. Despite being lower than previous proposals, it remains a significant hike. The Swedish government and manufacturers argue that the tax treats pouches like cigarettes instead of considering their lower harm. While the compromise aims to modernize regulations for various tobacco products, Sweden's successful harm-reduction model could be compromised. Concerns about the impact on consumers and illicit trade have stalled negotiations. Swedish stakeholders are urged to resist these tax increases, emphasizing the need for a risk-based tax framework.

Restrictions on flavoured e-cigarettes are reshaping how consumers engage with nicotine products. Data analysed by the National Bureau of Economic Research, with a focus on China, illustrates how limits on non-tobacco flavours influence user behaviour and product choices. The findings suggest that such policies can significantly alter consumption patterns, often producing unintended effects. In some cases, reducing access to flavored alternatives may lead users back to traditional cigarettes. These insights contribute to the ongoing global debate on regulation and harm reduction strategies.

Across Europe, the debate over harm reduction is becoming increasingly polarised, especially around nicotine pouches and other smoke-free alternatives. Advocates argue that these products offer real-life benefits to smokers trying to quit, pointing to examples like Sweden’s declining smoking rates. Critics, particularly within EU institutions and some national governments, are pushing for stricter regulations or outright bans. The clash highlights a deeper divide between policy-makers and consumers, with accusations that regulations ignore lived experiences and practical outcomes. At stake is not only public health strategy, but also the question of whether innovation in nicotine alternatives should be encouraged or restricted.